Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

First time ultra-sensitive and simultaneous quantification of proteins, interactions, and post-translational modifications in single cells to enable exponential growth in proteomics and interactomics

Project description

Disruptive tool enables step change in proteomics and ‘interactomics’

In a few short decades, scientific advances have made it possible to sequence entire genomes in less than an hour. The genomes are one piece of the puzzle and are relatively unchanged throughout an organism’s life. Deeper understanding requires knowledge about protein expression and protein-protein interactions (PPIs), both of which are modulated over time by a plethora of factors. Scientists currently lack adequate methods to investigate this. The EIC-funded PICO-NGS project aims to pave the way to market for its disruptive single-cell proteomics tool. It combines ultra-high sensitivity with unprecedented ‘parallelism’, measuring proteins, PPIs and post-translational modifications simultaneously in hundreds of individual cells. Applications in pharma, biotech and agrotech abound.

Objective

In a human cell there are about 20k protein coding genes (genome) that originate ~100k proteins (proteome). Proteins are involved in complex networks of protein-protein interactions (PPIs) influenced by post-translational modifications (PTMs), the interactome of living cells (~800,000 entities). The genome is mostly static throughout cell lifetime and can be sequenced today in <1h. The proteome and interactome are changing with e.g. environment and health, and not yet fully known. Today's methods for proteomics and interactomics are tedious, and lack sensitivity, quantitativity and parallelism.
PICO-NGS combines ultra-high sensitivity (>10 fM) with high parallelism measuring proteins, PPIs, and PTMs simultaneously (>50 targets). This will disrupt the global proteomics market (€29 B worth, 16% CAGR). This will fertilise ground-breaking academic research and accelerate developments in e.g. Pharma (drug discovery), Biotech (biomarkers/diagnosis), and Agrotech (crop sciences) industries.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended Finance

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2022-ACCELERATOR-01

See all projects funded under this call

Coordinator

ACTOME GMBH
Net EU contribution
€ 2 498 125,00
Address
GEORGES-KOHLER-ALLEE 103
79110 Freiburg im Breisgau
Germany
SME
Yes
Region
Baden-Württemberg Freiburg Freiburg im Breisgau, Stadtkreis
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 3 568 750,00